November 19, 2025

What the Storms Left Behind Was Worse

Severe storm-related mold infestations are contributing to ongoing respiratory and systemic health risks amid significant delays in remediation and disaster recovery support.

KFF Health News

November 18, 2025

Plozasiran Wins FDA Nod for FCS

Arrowhead’s small interfering RNA therapy reduced triglycerides and lowered pancreatitis risk in the phase 3 PALISADE trial, providing a quarterly self-administered option for patients with familial chylomicronemia syndrome.

Conexiant

November 12, 2025

Radiation Training Levels May Influence Safety Culture

Researchers examine how radiation knowledge shapes health care safety attitudes.

Conexiant

November 10, 2025

Hidden Vitamin K Deficiencies Driving Bleeding Risks

Researchers outline advanced laboratory methods to improve diagnosis of congenital and acquired coagulopathies.

Conexiant

November 05, 2025

FDA Approves First Pediatric IBS-C Treatment

Linzess becomes the first treatment cleared for pediatric irritable bowel syndrome with constipation.

Conexiant

November 05, 2025

Shame in Medicine—A Quiet Epidemic

A new movement in medicine aims to teach “shame competence,” helping physicians recognize and manage one of the field’s most corrosive yet overlooked emotions.

KFF Health News

November 03, 2025

Settlement Cash: Misused or Misread?

Opioid settlement funds were used for R&B concerts promoting addiction awareness in Irvington, New Jersey, highlighting broader debates over how opioid restitution money is spent nationwide.

KFF Health News

October 29, 2025

H-1B Visa Changes: Who Pays the Price?

New fee structure could hit hardest where physicians are needed most.

Conexiant

October 27, 2025

Why Open Access May Not Boost Citations

Researchers found that companion open access journals charge high publication fees yet yield fewer citations than traditional journals.

Conexiant